PT-141 is a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors across the body, resulting to enhanced sexual performance. Clinical studies have indicated that PT-141 could effectively treat a spectrum of sexual dysfunctions in b